News and Insights

3.03.25

Dykema Advises Wellgistics Health, Inc. on Nasdaq IPO

Congratulations to Dykema’s client, Wellgistics Health, Inc. (Nasdaq: WGRX), on the successful completion of its initial public offering (IPO). Wellgistics’ common stock began trading on the Nasdaq…

2.27.25

Dykema Advises PowerUp Acquisition Corp. in Aspire Biopharma’s Nasdaq Listing

Congratulations to Dykema’s client, PowerUp Acquisition Corp., in its successful business combination with Aspire Biopharma Holdings, Inc. (Nasdaq: ASBP), a developer of patent-protected disruptive…

11.14.24

Andrew Frost and Robin Lehninger Recognized by Wisconsin Super Lawyers as “Rising Stars” for 2024

Dykema, a leading national law firm, announced today that two of its Milwaukee-based attorneys were recognized as a 2024 “Rising Stars” in the Wisconsin edition of Super Lawyers.

4.26.22

SPAC, IPO or Private Equity: Which Exit Fits, and Are You Ready?

Kate Bechen participated in the American Health Law Association’s Health Care Transactions 2022 program on April 26, 2022. Bechen’s session, “SPAC, IPO or Private Equity: Which Exit Fits, and Are You…